Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers
Sunday, October 4, 2015 - 19:10
in Mathematics & Economics
A pharmaceutical company buys old drugs and increases the price multifold, a profitable business model that is drawing anger and making the traditional drug industry nervous.